Publication:
The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source

Keywords

Citation

Doymaz M. Z., Aydın B. N., Çetin N. S., Kaygusuz A., \"The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells\", 5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V) Scientific Programme, İzmir, Türkiye, 20 - 22 Ekim 2022, ss.38

Endorsement

Review

Supplemented By

Referenced By

1

Views

0

Downloads


Sustainable Development Goals